PAH Exercise Study

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT06941441
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Exercise Therapy
  • Pulmonary Arterial Hypertension (PAH)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Home exercise program — OTHER
    A tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring

Study Details

Ten patients with PAH who are stable and eligible to initiate sotatercept therapy will participate in a 26 week study that consists of a 24-week intervention period where patients will receive complimentary sotatercept as prescribed, plus a tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring.

Key Dates

Start date
Apr 15, 2025
Status verified
Apr 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Exercise Arm
    Patients with PAH on sotatercept plus a tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring

Primary Outcome Measure

Recruitment rate [ Time Frame: 18 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of WashingtonSeattleWashington98195
Claire E Child, DPT, MPH
[email protected]
206-616-8601

Find similar trials in Seattle, WA

By research site
University of Washington· Seattle, WA

Related Studies